Prestige Consumer Healthcare Inc.
PBH · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1.1% | -0.2% | 3.8% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 55.8% | 55.5% | 55.4% | 57.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 29.6% | 30.4% | -2% | 30.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 18.9% | 18.6% | -7.3% | 18.9% |
| EPS | 4.32 | 4.21 | -1.65 | 4.09 |
| % Growth | 2.6% | 355.2% | -140.3% | – |
| EPS Diluted | 4.29 | 4.17 | -1.65 | 4.04 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.8% | 33.2% | 0.7% | 33% |